Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Shire deepens rare disease focus with NPS buyout

26 January 2015 Business

Approval of parathyroid hormone drug further validates acquisition decision

UK calls for fracking restrictions

26 January 2015 Business

Environment committee wants to protect national parks and tighten regulation

Biogen Idec to buy Convergence for pain pipeline

12 January 2015 Business

UK firm will remain intact as a ‘centre of excellence’ in pain R&D for Biogen

EU recommends Parkinson’s drug for approval

24 December 2014 Business

First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials

EU chemicals regulator scolded over animal testing

24 December 2014 Business

Ombudsman says ECHA isn’t doing enough to require alternative, non-animal methods

Consumer products firms fined for French price fixing

23 December 2014 Business

€950m fines for ‘friends clubs’ that pushed up prices for home and personal care products

Solving iron’s solubility problem

10 December 2014 Business

Technology profile: MRC Human Nutrition Research - anaemia supplements with fewer side effects

Otsuka to buy neurology specialist Avanir

4 December 2014 Business

$3.5bn deal adds to Otsuka’s mental health portfolio and strengthens its US presence

Syngenta to cut or relocate 1800 jobs in 2015

26 November 2014 Business

Global reorganisation plan will involve ‘consolidation’ of R&D facilities

UCB sells speciality generics subsidiary

26 November 2014 Business

Firm will use $1.5bn proceeds to reduce debt and concentrate on developing new drugs in neurology and immunology

Labcorp to buy Covance and enter contract research

12 November 2014 Business

Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal's value

Lanxess to cut 1000 jobs over two years

11 November 2014 Business

Agrium also cutting 500 positions and divesting underperforming business segments

Perrigo to buy Omega Pharma for €3.6bn

11 November 2014 Business

Deal strengthens Perrigo’s over-the-counter portfolio and pushes strongly into Europe

Chinese buyer resurrects US Boehringer plant

3 November 2014 Business

UniTao will take over manufacturing site scheduled for closure, saving over 200 jobs

Platform to expand in agrochemicals by buying Arysta

29 October 2014 Business

Business will be integrated with previous acquisitions for a broad crop protection portfolio

EU warns DuPont and Honeywell over green refrigerants

29 October 2014 Business

Commission thinks cooperation may have been anti-competitive

Judge slashes fines in drug safety case

29 October 2014 Business

Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million

CHF3bn redevelopment for Roche’s Basel site

29 October 2014 Business

New buildings will move employees out of rented office space

Amgen stacks up additional job cuts

28 October 2014 Business

Up to 1100 more staff face redundancy in ongoing restructuring plan

AbbVie backs out of Shire deal

17 October 2014 Business

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits

Endo outbids QLT for Auxilium merger

10 October 2014 Business

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo

EMA finalises trial transparency rules

8 October 2014 Business

Researcher access reinstated, but company redaction rights may cause issues

Actavis boosts antibiotics with Durata buyout

8 October 2014 Business

$820 million deal gives Actavis control of newly-approved intravenous antibiotic

Becton Dickinson to buy CareFusion for $12bn

7 October 2014 Business

Medical devices merger continues consolidation trend

J&J to buy antiviral specialist Alios

1 October 2014 Business

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus